Pain Clinical Trial
— ASCyDOfficial title:
Assessment of Analgesia, Sedation, Physical Restraints and Delirium in Patients Admitted to Spanish Intensive Care Units. ASCyD Project
NCT number | NCT03773874 |
Other study ID # | PY 17/22 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | February 12, 2018 |
Est. completion date | March 11, 2018 |
Verified date | February 2018 |
Source | Hospital Universitario Getafe |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
This study assess which Spanish intensive care units evaluate and record, in a standardized way, levels of pain, sedation / agitation, use of physical restraints and prevalence of delirium. Also determine the use of validated assessment tools and explore levels of pain and sedation / agitation, use of physical restraints and prevalence of delirium.
Status | Completed |
Enrollment | 1574 |
Est. completion date | March 11, 2018 |
Est. primary completion date | February 25, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - All adult patients who were admitted to the participating units at the time of the audit and had a minimum stay of 24 hours in the unit. Exclusion Criteria: - no criteria |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Universitario de Getafe | Getafe | Madrid |
Lead Sponsor | Collaborator |
---|---|
Hospital Universitario Getafe |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Communicative patient's pain with Numeric Rating Scale (NRS) in critical care units. | Primary assessment of pain. NRS scale's range from 0 to 10. 0: no pain; 1-3: light pain; 4-6: moderate pain; 7-10: severe pain | one day | |
Primary | "Non communicative" patient's pain with Behavioural Indicators of Pain Scale (ESCID) in critical care units. | Primary assessment of pain ESCID scale's range from 0 to 10. 0: no pain; 1-3: light pain; 4-6: moderate pain; 7-10: severe pain | one day | |
Primary | Communicative and "no communicative" patient's sedation/agitation level's with Richmond Agitation Sedation Scale (RASS) in critcal care units. | Primary assessment of sedation/agitation level' s. RASS scale range from -5 to +5. -4 to -5: depth sedation; -3 to -1: light sedation; 0: aware; +1 to +4: agitation. | one day | |
Primary | Communicative and "no communicative" patient's delirium prevalence with Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) in critical care units | Primary assessment of delirium | one day | |
Primary | Use of physical restraints on Communicative and "no communicative" patient's in critical care units | Primary assessment of use of physical restraints | one day | |
Secondary | use of validated scale of pain: Numeric Rating Scale (NRS) | use of validated scales of pain for communicative patients. NRS scale's range from 0 to 10. 0: no pain; 1-3: light pain; 4-6: moderate pain; 7-10: severe pain. | one day | |
Secondary | use of validated scale of pain: Visual Analog Scale (VAS) | use of validated scales of pain for communicative patients. VAS, scale's range from 0 to 10. 0: no pain; 1-3: light pain; 4-6: moderate pain; 7-10: severe pain. | one day | |
Secondary | use of validated scale of pain: Campbell scale | use of validated scales of pain for "non communicative" patients. Campbell scale's range from 0 to 10. 0: no pain; 1-3: light pain; 4-6: moderate pain; 7-10: severe pain. | one day | |
Secondary | use of validated scale of pain: Behavioural Indicators of Pain Scale (ESCID) | use of validated scales of pain for "non communicative" patients. ESCID scale's range from 0 to 10. 0: no pain; 1-3: light pain; 4-6: moderate pain; 7-10: severe pain. | one day | |
Secondary | use of validated scales of pain: Behavioral Pain Scale (BPS) | use of validated scales of pain for "non communicative" patients. scale's range from 3 to 12; 3: no pain, high number more pain. | one day | |
Secondary | use of validated scales of pain: Critical-Care Pain Observation Tool (CPOT) | use of validated scales of pain for "non communicative" patients. CPOT: range from 0 to 8; 0-2: no pain, > 2 pain. | one day | |
Secondary | use of validated scales of sedation/agitation (RASS) | use of validated scales of sedation/agitation patients. RASS scale range from -5 to +5. -4 to -5: depth sedation; -3 to -1: light sedation; 0: aware; +1 to +4: agitation. | one day | |
Secondary | use of validated scales of sedation/agitation (Ramsay scale) | use of validated scales of sedation/agitation patients. Ramsay score from 1 to 6; 1: anxious, agitated restless, 2: cooperative, oriented, tranquil, 3: responsive to commands only, 4: brisk response to light glabellar tap or loud auditory stimulus, 5: sluggish response to light glabellar tap or loud auditory stimulus, 6: no response to light glabellar tap or loud auditory stimulus. | one day | |
Secondary | use of validated scales of delirium (Intensive Care Delirium Screening Checklist (ICDSC)) | Use of validated scales of delirium. ICDSC is positive (delirium present) or negative (no delirium). | one day | |
Secondary | use of validated scales of delirium (CAM-ICU) | Use of validated scales of delirium. CAM-ICU is positive (delirium present) or negative (no delirium). | one day | |
Secondary | protocols of pain and sedation | Presence of protocols in the critical care units | one day | |
Secondary | protocols of use of physical restraints | Presence of protocols in the critical care units | one day | |
Secondary | protocols of management of delirium | Presence of protocols in the critical care units | one day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|